Skip to main content
Premium Trial:

Request an Annual Quote

Veracyte Secures NY State Approval for Genomic Classifier Test for Lung Disease

NEW YORK (GenomeWeb) – Veracyte has received regulatory approval from the New York State Department of Health to offer its Envisia Genomic Classifier test to patients in the state immediately, the company said on Monday. The test uses RNA sequencing and machine learning to help distinguish idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases (ILD) without surgery.

The approval follows the publication of a clinical study of the assay earlier this month and a Medicare local coverage determination for Envisia last month to be used as a complement to high-resolution computed tomography in some cases.

"This milestone, along with a recent Medicare coverage policy, underscores the strength of the clinical evidence behind the Envisia classifier and the critical need for better diagnosis among patients being evaluated for ILDs, including IPF," Veracyte CEO Bonnie Anderson said in a statement. 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.